LETTER TO THE EDITOR
Int. J. Public Health
Lessons to be learned from the COVID-19 Pandemic: some further ideas
Align Healthcare & Health Foundation, Milan, Italy
Article metrics
14
Views
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Lessons to be learned from the COVID-19 Pandemic: some further ideas characters 68 389 characters Quinn et al.1 have done an exceptional work. I offer some further suggestion. The Authors state: (page 8) "the progression of the pandemic was largely independent of government measures". Indeed, some government measures were even counterproductive for hard outcomes. For example, all-cause mortality excess in 2020 (pre-vaccination era) versus mean mortality 2015-2019 (Our World in Data) was not favorably associated with the lockdown index (Oxford University Database). Rather, it was slightly unfavorably associated with mortality both globally, and in subanalysis by gross domestic product per capita ($ <21,000; 21,000 to <45,000; ≥45,000), population size (<17; 17 to 50, >50 M), population density (inhabitants per km2: <100, 100 to <1000, ≥1000), and proportion of elderly people (75-84, or ≥85 years). (page 15) "the incidence of… transient myocarditis and/or pericarditis is not 'rare', but rather 'uncommon'". The correct term is 'common' (i.e. 2.33-2.8% in the two cited1 studies, as per international rules). (page 16) "some studies comparing all-cause mortalities between vaccinated and unvaccinated groups found slightly increased risks among vaccinated groups". Indeed, in the cited study, in the two years 2021 and 2022, the mortality risk in vaccinated people with one or two doses was statistically significant, and twice or more than the risk of unvaccinated. Moreover, a study based on the UK Office for National Statistics (ONS) data2 shows that the regression lines, both for all-cause deaths and for non-COVID-19 deaths, start from very low values for all the age groups, with almost linear progressive increases as the months progress. For the age groups 18-39, 80-89 and 90+ years, both regression lines intersect and overcome the reference line of unvaccinated during the study period. The same occurs for the age 50-59, limited to non-COVID-19 deaths. For the other age groups, the month of the intersection was predicted calculating the angular coefficients. The last intersections would have occurred in 2024, but the ONS stopped publishing mortality data by vaccination status after May 2023. (page 17) "by late 2021, it was abundantly clear that the vaccines did not prevent COVID-19 infection". Indeed, by March 2022 it was clear that, in the Delta variant era, they did not prevent even the transmission; instead, they significantly increase the transmission from infected people, ≥90 days after dose 2.3 Moreover, many recent studies (e.g.4,5) showed that multiple inoculations are progressively and proportionally associated with SARS-CoV-2 infections.
Summary
Keywords
COVID-19 lockdown, COVID-19 vaccine myo-pericarditis, vaccinated vs unvaccinated, Mortality, infection and transmission
Received
28 August 2025
Accepted
17 December 2025
Copyright
© 2025 Donzelli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alberto Donzelli
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.